4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-25-000006
Chief Medical Officer sold 11,367 shares at an average $36.00 ($409,266)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-09-15 | Sale 10b5-1 | −9,302 | $35.90 | $333,946 | 83,589 | D |
| Rodman David Malcom Chief Medical Officer | 2025-09-15 | Sale 10b5-1 | −2,065 | $36.47 | $75,320 | 81,524 | D |
| Open-market sales · 11,367 sh · avg $36.00 · $409,266 | |||||||
Loading xslF345X05/wk-form4_1758063276.xml…